Ranking Profile - Helixmith Co Ltd

Introduction

Helixmith Co Ltd (Helixmith), discovers and develops DNA, protein-based therapeutics, herbal medicines and nutraceuticals for treating various ischemic diseases or neurodegenerative disorders. The company developed Engensis (VM202), a plasmid DNA therapy used to express two isoforms of hepatocyte growth factor and treat various neurodegenerative diseases such as diabetic peripheral neuropathy, diabetic foot ulcer and coronary artery disease. It develops a VM206 program for treating breast cancer and a VM501 program against thrombocytopenia, a deficiency of blood platelets caused due to chemotherapy. Helixmith also investigating various programs to treat chronic wounds, peripheral arterial diseases and claudication. The company uses plasmid DNA (pCK) and AAV vector technology to treat neuromuscular and muscle diseases. It has a manufacturing facility in San Diego, California, the US. Helixmith is headquartered in Seoul, South Korea.